Sep 8th, 2015

The US patent office granted patent 8,947,656, entitled “Smartphone biosensor” to the University of Illinois and inventor Prof. Brian T. Cunningham.  An option and license agreement for this and other related intellectual property has been negotiated with Exalt Diagnostics.

Sep 8th, 2015

In a paper published in Biomedical Optics Express (Vol. 5, No. 11, p. 3792), the Cunningham group describes the use of a smartphone-based spectrometer to perform ELISA assays with the same level of sensitivity performance as a laboratory instrument.  ELISA represents the most common assay protocol, with exiting tests for thousands of diseases.  In the paper, detection of peanut allergen in grocery store cookies was demonstrated as a representative example.

Sep 15th, 2013

NIH National Cancer Institute awards a grant under its highly competitive Innovative Molecular Analysis Technologies (IMAT) program to a team comprised of Prof. Brian T. Cunningham at the University of Illinois, Prof. Karen Anderson at Arizona State University, and Dr. Richard P. Zangar at Pacific Northwest National Laboratory.  The three-year program will enable translation of FluoroBoost™ technology from the laboratory to a clinically validated diagnostic platform for multiplexed detection of a set of ten breast cancer biomarkers in a single droplet of serum.  The aims of the grant are targeted at development of a technology that can complement mammography, which provides an unacceptably high number of false positive results.